Gå til hovedindhold
Veterinary Medicines

Kaltetan forte, 458.4 mg/ml + 125 mg/ml + 20 mg/ml solution for infusion for horses, cattle and pigs

Authorised
  • CALCIUM GLUCONATE FOR INJECTION
  • Magnesium chloride hexahydrate
  • Sodium glycerophosphate pentahydrate

Produktidentifikation

Lægemidlets navn:
Kaltetan forte, 458,4 mg/ml + 125 mg/ml + 20 mg/ml solução para perfusão para equinos, bovinos e suínos
Kaltetan forte, 458.4 mg/ml + 125 mg/ml + 20 mg/ml solution for infusion for horses, cattle and pigs
Aktiv substans:
Dyrearter:
  • Hest
  • Kvæg
  • Svin
Administrationsvej:
  • Intravenøs anvendelse

Produktoplysninger

Aktiv substans / Styrke:
  • Kun tilgængelig på English
    458.40
    milligram(s)
    /
    1.00
    millilitre(s)
  • Kun tilgængelig på English
    125.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Kun tilgængelig på English
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Lægemiddelform:
  • Infusionsvæske, opløsning
Withdrawal period by route of administration:
  • Intravenous use
    • Hest
      • Milk
        5
        week
    • Kvæg
      • Meat and offal
        5
        week
    • Svin
      • Meat and offal
        5
        week
Anatomisk terapeutisk kemisk veterinær (ATCvet) kode:
  • QA12AX
Godkendelsesstatus:
  • Valid
Authorised in:
  • Portugal
Available in:
  • Portugal
Pakningsbeskrivelse:

Yderligere oplysninger

Entitlement type:
Indehaver af markedsføringstilladelsen:
  • Vet-Agro Multi-Trade Company Sp. z o.o.
Marketing authorisation date:
Produktionssteder for batchfrigivelse:
  • Multi-Trade Company "Vet-Agro" Sp. z o.o.
Ansvarlig myndighed:
  • Directorate General For Food And Veterinary
Markedsføringstilladelsesnummer:
  • 1495/02/22DFVPT
Dato for ændring af godkendelsesstatus:
Procedurenummer:
  • PL/V/0110/002
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."